Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5-alpha reductase inhibitor treated human benign prostate hyperplasia patients.
Prostate. 2022 Oct;82(14):1378-1388. doi: 10.1002/pros.24410. Epub 2022 Jul 12.
Prostate. 2022.
PMID: 35821619
Free PMC article.
The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
Jin R, Strand DW, Forbes CM, Case T, Cates JMM, Liu Q, Ramirez-Solano M, Milne GL, Sanchez S, Wang ZY, Bjorling DE, Miller NL, Matusik RJ.
Jin R, et al.
Prostate. 2021 Sep;81(13):944-955. doi: 10.1002/pros.24190. Epub 2021 Jul 20.
Prostate. 2021.
PMID: 34288015
Free PMC article.
Item in Clipboard
Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
Popovics P, Awadallah WN, Kohrt SE, Case TC, Miller NL, Ricke EA, Huang W, Ramirez-Solano M, Liu Q, Vezina CM, Matusik RJ, Ricke WA, Grabowska MM.
Popovics P, et al.
Prostate. 2020 Jul;80(10):731-741. doi: 10.1002/pros.23986. Epub 2020 May 1.
Prostate. 2020.
PMID: 32356572
Free PMC article.
Item in Clipboard
Cite
Cite